Abstract

As a species the mouse is highly resistant to atherosclerosis. However, through induced mutations it has been possible to develop lines of mice that are susceptible to this disease. For example, mice that are deficient in apolipoprotein E, a ligand important in lipoprotein clearance, develop atherosclerotic lesions resembling those observed in humans. These lesions are exacerbated when the mice are fed a high-cholesterol, high-fat, Western-type diet. Other promising models are mice that are deficient in the low density lipoprotein receptor and transgenic mice that express human apolipoprotein B and transdominant mutant forms of apolipoprotein E. These models are now being used to study the pathogenesis of atherosclerotic lesions, as well as the influence of genetics, environment, hormones, and drugs on lesion development.

Keywords

Apolipoprotein BGenetically modified mousePathogenesisMutantLipoproteinApolipoprotein ETransgeneBiologyLesionLDL receptorReceptorCholesterolDiseaseEndocrinologyInternal medicineImmunologyGeneMedicineGeneticsPathology

Affiliated Institutions

Related Publications

Publication Info

Year
1996
Type
review
Volume
272
Issue
5262
Pages
685-688
Citations
692
Access
Closed

External Links

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

692
OpenAlex

Cite This

Jan L. Breslow (1996). Mouse Models of Atherosclerosis. Science , 272 (5262) , 685-688. https://doi.org/10.1126/science.272.5262.685

Identifiers

DOI
10.1126/science.272.5262.685